X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6517) 6517
deoxycytidine - analogs & derivatives (6456) 6456
science & technology (5301) 5301
life sciences & biomedicine (5194) 5194
female (4969) 4969
middle aged (4433) 4433
deoxycytidine - administration & dosage (4381) 4381
male (4219) 4219
aged (4151) 4151
oncology (3909) 3909
deoxycytidine - adverse effects (3380) 3380
adult (3368) 3368
antineoplastic combined chemotherapy protocols - therapeutic use (3274) 3274
antineoplastic combined chemotherapy protocols - adverse effects (2538) 2538
treatment outcome (2329) 2329
gemcitabine (2243) 2243
deoxycytidine - therapeutic use (2049) 2049
chemotherapy (1987) 1987
fluorouracil - analogs & derivatives (1954) 1954
capecitabine (1944) 1944
cancer (1617) 1617
fluorouracil - administration & dosage (1440) 1440
aged, 80 and over (1384) 1384
antimetabolites, antineoplastic - adverse effects (1257) 1257
drug administration schedule (1139) 1139
pancreatic neoplasms - drug therapy (1104) 1104
disease-free survival (1077) 1077
antimetabolites, antineoplastic - therapeutic use (1011) 1011
fluorouracil - adverse effects (1008) 1008
cisplatin - administration & dosage (1002) 1002
care and treatment (991) 991
lung neoplasms - drug therapy (965) 965
neoplasm staging (959) 959
pharmacology & pharmacy (953) 953
antineoplastic combined chemotherapy protocols - administration & dosage (914) 914
antimetabolites, antineoplastic - administration & dosage (893) 893
pancreatic cancer (885) 885
medicine & public health (863) 863
survival analysis (801) 801
survival rate (787) 787
research (783) 783
carcinoma, non-small-cell lung - drug therapy (782) 782
adenocarcinoma - drug therapy (758) 758
breast neoplasms - drug therapy (742) 742
retrospective studies (666) 666
clinical trials (665) 665
pancreatic neoplasms - pathology (662) 662
organoplatinum compounds - administration & dosage (637) 637
dose-response relationship, drug (619) 619
drug therapy (619) 619
neoplasm metastasis (619) 619
metastasis (614) 614
antineoplastic agents (592) 592
fluorouracil - therapeutic use (582) 582
paclitaxel - administration & dosage (568) 568
antimitotic agents (562) 562
disease progression (539) 539
hematology, oncology and palliative medicine (534) 534
prognosis (513) 513
kaplan-meier estimate (503) 503
cancer research (479) 479
cisplatin (479) 479
antineoplastic agents - therapeutic use (471) 471
combined modality therapy (470) 470
colorectal neoplasms - drug therapy (469) 469
pharmacology/toxicology (458) 458
analysis (453) 453
prospective studies (451) 451
follow-up studies (446) 446
breast neoplasms - pathology (443) 443
cisplatin - adverse effects (436) 436
taxoids - administration & dosage (435) 435
lung neoplasms - pathology (431) 431
infusions, intravenous (417) 417
breast cancer (403) 403
dosage and administration (403) 403
antineoplastic agents - adverse effects (402) 402
maximum tolerated dose (397) 397
toxicity (397) 397
time factors (396) 396
chemotherapy, adjuvant (389) 389
health aspects (388) 388
carboplatin - administration & dosage (380) 380
colorectal cancer (378) 378
oncology, experimental (377) 377
neutropenia - chemically induced (371) 371
patients (370) 370
adenocarcinoma - pathology (366) 366
cancer therapies (365) 365
carcinoma, non-small-cell lung - pathology (364) 364
pancreatic neoplasms - mortality (356) 356
camptothecin - analogs & derivatives (353) 353
oxaliplatin (353) 353
vinblastine - analogs & derivatives (353) 353
drug therapy, combination (352) 352
neoplasms - drug therapy (351) 351
abridged index medicus (348) 348
radiotherapy (346) 346
administration, oral (344) 344
vinblastine - administration & dosage (344) 344
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6378) 6378
Japanese (163) 163
Chinese (91) 91
French (70) 70
German (52) 52
Spanish (27) 27
Russian (18) 18
Italian (14) 14
Dutch (13) 13
Hungarian (8) 8
Portuguese (5) 5
Danish (3) 3
Polish (3) 3
Czech (2) 2
Bosnian (1) 1
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Lithuanian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 7, pp. 581 - 589
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2015, Volume 385, Issue 9987, pp. 2606 - 2615
Summary Background Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Arthralgia - chemically induced | Thiazoles - adverse effects | Sleep Initiation and Maintenance Disorders - chemically induced | Tenofovir | Adenine - adverse effects | Quinolones - adverse effects | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Headache - chemically induced | Emtricitabine | Adenine - analogs & derivatives | Kidney - drug effects | Respiration Disorders - chemically induced | Double-Blind Method | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Nausea | Adenine - administration & dosage | Organophosphonates - administration & dosage | Bone Density - drug effects | Quinolones - administration & dosage | Carbamates - adverse effects | HIV Infections - drug therapy | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Medical colleges | Clinical trials | Cross infection | Nosocomial infections | HIV (Viruses) | Drug therapy | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Infections | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 4/2013, Volume 207, Issue 7, pp. 1157 - 1165
Background. Human immunodeficiency virus (HIV)-infected patients on combination active antiretroviral therapy (cART) are at increased risk of age-related... 
T lymphocytes | HIV/AIDS | Telomeres | Antiretrovirals | HIV | Final causes | Cell lines | Nucleosides | Reverse transcriptase inhibitors | Carts | Disease risks | telomerase | aging | HIV infection | antiretroviral therapy | telomere | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Humans | Middle Aged | Aging - drug effects | Antiretroviral Therapy, Highly Active - adverse effects | Male | Telomere - drug effects | Case-Control Studies | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Young Adult | Telomere Shortening | Adenine - adverse effects | HIV Infections - pathology | Time Factors | Polymerase Chain Reaction | Adult | Deoxycytidine - adverse effects | Female | Telomerase - metabolism | Dideoxynucleosides - adverse effects | Emtricitabine | Adenine - analogs & derivatives | Leukocytes, Mononuclear - drug effects | Zidovudine - adverse effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Risk Factors | Cells, Cultured | Organophosphonates - adverse effects | HIV - pathogenicity | Enzyme Activation - drug effects | Regression Analysis | Telomere - enzymology | HIV Infections - drug therapy | Leukocytes, Mononuclear - enzymology | Telomerase - antagonists & inhibitors | Deoxycytidine - analogs & derivatives | Complications and side effects | Demographic aspects | Physiological aspects | Aging | Research | Telomerase | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 07/2014, Volume 12, Issue 7, pp. 1028 - 1059
The NCCN Guidelines for Colon Cancer address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance,... 
Life Sciences & Biomedicine | Oncology | Science & Technology | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Colonic Neoplasms - drug therapy | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Bevacizumab | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Deoxycytidine - adverse effects | Leucovorin - therapeutic use | Cetuximab | Liver Neoplasms - secondary | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Camptothecin - therapeutic use | Fluorouracil - analogs & derivatives | Membrane Proteins - genetics | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | GTP Phosphohydrolases - genetics | Proto-Oncogene Proteins B-raf - genetics | Colonic Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 238 - 246
... transcriptase inhibitor (NNRTI), efavirenz, in combination with tenofovir-disoproxil-fumarate and emtricitabine.1–4 However, efavirenz is associated with several adverse... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Dosage and administration | Efavirenz | Patient outcomes | Clinical trials | Antiretroviral drugs | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2006, Volume 354, Issue 3, pp. 251 - 260
Journal Article